Omega-3 fatty acids (EPA and DHA) are one of the few supplements with genuinely solid human evidence behind one specific claim: they lower triglycerides, a blood fat tied to heart risk. Beyond that, the picture is more honest than the marketing suggests. Large, recent, well-run trials looking at broad heart and brain ageing have been mixed and mostly modest, not the slam-dunks the “fish oil for longevity” headlines imply. Omega-3 is useful for particular jobs. It is not a proven anti-ageing pill, and for most people two servings of fish a week does the work.

The short answer

If you have high triglycerides, omega-3 reliably brings them down, and that is strong human evidence. If you are hoping it will prevent heart attacks, protect your memory, or slow ageing in general, the human evidence is mixed and underwhelming, especially in healthy people taking ordinary supplement doses. The strongest single positive heart trial used a high-dose, prescription, EPA-only product in high-risk patients already on statins, and even that result is debated. So: worth it for a defined reason, optional otherwise, and food usually beats the capsule.

What omega-3 is and how it works

“Omega-3” is a family of fats. The two that matter for the body are the long-chain marine forms: EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), found in oily fish and in algae. A third, ALA (alpha-linolenic acid), comes from plants like flax and walnuts, but humans convert only a small fraction of ALA into EPA and DHA, so ALA is not a reliable substitute.

Mechanistically, EPA and DHA do several plausible things. DHA is a structural building block of cell membranes, concentrated in the brain and the retina. Both are precursors to signalling molecules that dampen inflammation, and both reduce the liver’s output of triglyceride-rich particles, which is the cleanest, best-understood effect. Plausible mechanisms are a starting point, not proof, so the real question is what happens in actual people.

The strongest evidence: triglycerides

This is the one place omega-3 clearly earns its place. A 2020 review of 23 studies covering close to 44,000 people found that EPA and DHA reduce triglycerides by roughly 15 percent, while leaving body fat and other blood lipids largely unchanged (Examine; NIH Office of Dietary Supplements). The effect is dose-dependent and larger in people who start with high triglycerides.

Evidence grade: strong human trials. This is why prescription-strength omega-3 is an established treatment for very high triglycerides. The catch is that lowering a number on a blood panel is not the same as preventing a heart attack, which is where things get murkier.

The mixed evidence: heart disease and ageing

For decades omega-3 was assumed to protect the heart, based on early observations and trials in heart-attack survivors. Then the big, modern, placebo-controlled trials arrived and complicated the story.

In the VITAL trial, nearly 26,000 healthy older adults took marine omega-3 or placebo for years. Major cardiovascular events were about 8 percent lower in the omega-3 group, a difference that was not statistically significant overall (VITAL principal results, PubMed). There were hints of benefit in some sub-analyses, such as heart attack specifically and in people who ate little fish, but sub-group hints are hypotheses, not conclusions.

Two large trials of high-dose products then pointed in opposite directions:

  • REDUCE-IT used about 4 g/day of a purified EPA-only prescription drug (icosapent ethyl) in high-risk patients already on statins, and found a meaningful reduction in cardiovascular events (Circulation review).
  • STRENGTH used a high-dose EPA plus DHA product in a similar population and found no benefit.

The two are hard to reconcile. REDUCE-IT’s result may reflect EPA specifically, the very high dose, the high-risk statin-treated population, or a quirk of its mineral-oil placebo, which some researchers argue flattered the comparison. The honest summary: a specific high-dose prescription EPA product helped a specific high-risk group, and that does not translate into “everyone should take fish oil for their heart.”

For the general, healthy population taking standard over-the-counter doses, the weight of evidence is that omega-3 supplements do little to nothing for cardiovascular events (NIH ODS; Mayo Clinic).

Evidence grade: mixed, and weaker the healthier you are.

Brain ageing and memory

This is where hope outruns data. The pitch is intuitive: DHA is abundant in the brain, so topping it up should protect thinking. The trials do not support it.

Cochrane reviews, which pool the best randomised trials, found that omega-3 supplements did not improve cognitive function in cognitively healthy older people, and did not help cognition, daily functioning, or quality of life in people who already had dementia over the periods studied (Cochrane: fish oils for prevention of dementia; Cochrane: omega-3 for treatment of dementia). The trials were rated high quality, which makes the null result more convincing, not less.

Evidence grade: mixed leaning negative for prevention; no clear benefit for treatment. If protecting your brain as you age is the goal, sleep, physical activity, blood-pressure control, and not smoking have far stronger evidence than any capsule.

Read the label: EPA and DHA, not “fish oil mg”

The single most useful practical skill here is reading the back of the bottle. A “1000 mg fish oil” softgel might contain only a few hundred milligrams of actual EPA plus DHA; the rest is other oils. Always add up the EPA and DHA numbers, which is the dose that matters.

For everyday use, the food-first benchmark is two portions of fish a week, one of them oily, and many people who supplement land somewhere in the range of 250–1000 mg combined EPA plus DHA per day. The multi-gram doses used in cardiovascular trials are a medical decision made with a doctor, not a sensible default to self-prescribe.

A few buying notes, named fairly and on the merits:

  • Quality and freshness matter more than brand. Rancid fish oil is common; a product that tastes strongly “off” may be oxidised. Reputable brands such as Nordic Naturals, Now Foods, and Thorne all sell standardised EPA/DHA products, so the choice is mostly about dose per capsule, freshness, and price.
  • Form is a minor consideration. Triglyceride forms may absorb slightly better than the cheaper ethyl-ester form, but the difference is modest next to simply taking an adequate dose consistently.
  • Algae oil for vegetarians and vegans. It supplies EPA and DHA directly and raises blood omega-3 comparably to fish oil in short human studies (NIH ODS, consumer). It costs more per gram, but it is the obvious plant-based choice.

Food first: when a free habit beats the pill

For most healthy people, the better move is not a supplement at all. National guidance is to eat at least two portions of fish a week, including one of oily fish such as salmon, sardines, mackerel, or trout (NHS). Whole fish delivers EPA and DHA alongside protein, iodine, and selenium, and the human evidence linking omega-3 to heart benefit has always been strongest for fish in the diet rather than capsules.

A supplement makes sense if you genuinely do not eat fish, follow a vegetarian or vegan diet (algae oil), or have been advised to lower triglycerides. If you already eat oily fish a couple of times a week, an extra capsule is unlikely to add much.

Safety and who should check first

At everyday doses omega-3 is well tolerated. The usual complaints are fishy aftertaste, burping, and mild stomach upset, which taking capsules with food can ease.

Two cautions are worth stating plainly. First, across the high-dose trials there is a small but consistent increase in atrial fibrillation, an irregular heartbeat, and the signal is larger at higher pharmaceutical doses (NIH ODS). At ordinary supplement doses the risk is low, but it is a reason not to mega-dose casually. Second, omega-3 can add to the blood-thinning effect of medicines such as warfarin and other anticoagulants.

See a doctor or pharmacist before starting if you take blood thinners, have a heart rhythm condition, are pregnant or breastfeeding, or have a chronic illness. And treat any persistent or worsening symptom as a reason to get checked rather than self-manage with a supplement. This article is educational and not a substitute for individual medical advice.

Who it suits, and who can skip it

Omega-3 is a reasonable, low-risk supplement for people with elevated triglycerides, people who rarely eat fish, and vegetarians or vegans who choose algae oil. For healthy people who already eat oily fish and are hoping to slow ageing, it is closer to optional, and the money may be better spent on the basics that actually move longevity: training, sleep, and diet quality.

To put omega-3 in the wider context of supplements that are worth it and those that are not, see our guide to the best longevity supplements and the broader question of whether longevity supplements work at all. For the compound with arguably the strongest human evidence of any in this category, read creatine and longevity; for the one most people are genuinely low in, vitamin D and longevity. And for the uncomfortable truth underneath all of it, habits beat supplements for longevity.

Sources